File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000081825
- Scopus: eid_2-s2.0-10844274568
- PMID: 15591775
- WOS: WOS:000225547000010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation
Title | Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation |
---|---|
Authors | |
Keywords | Astrocytes Cell culture Neuronal cells Neuropeptide Y Neuropeptide Y receptor Neuroprotection |
Issue Date | 2004 |
Publisher | Springer Verlag Dordrecht. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1021-7770 |
Citation | Journal Of Biomedical Science, 2004, v. 11 n. 6, p. 781-788 How to Cite? |
Abstract | In this in vitro study, we investigated the influence of neuropeptide Y (NPY) Y1 receptor activation or inhibition on the viability of cultured neuronal or glial cells following oxygen glucose deprivation (OGD). Viability of cultured cells was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide. When compared to the vehicle-treated control group, treatment with NPY or [Leu31,Pro34]-NPY (Y1 agonist) reduced viability of cultured SK-N-MC (Y1-expressing) human neuronal cells at 24 h after 1 h of OGD, while BIBP3226 (Y1 antagonist) improved viability. Except at the highest concentration of NPY used in the study, treatment with NPY or NPY3-36 (Y2 agonist) did not influence viability of cultured SH-SY5Y (Y2-expressing) human neuronal cells at 24 h after 1 h of OGD. In addition, treatment with NPY, [Leu31,Pro34]-NPY, NPY3-36, or BIBP3226 did not affect viability of cultured primary astrocytes at 24 h after 4 h of OGD. The present results agree with those of a recent in vivo study. Activation of NPY-Y1 receptors may mediate ischemic pathophysiological processes, and inhibiting the Y1 receptors may be protective. The combination of OGD and cultured neuronal cells may be useful in future studies on the neuroprotective and harmful mechanisms of NPY-Y1 receptor inhibition and activation during ischemia, respectively. Copyright © 2004 National Science Council, ROC and S. Karger AG, Basel. |
Persistent Identifier | http://hdl.handle.net/10722/78483 |
ISSN | 2023 Impact Factor: 9.0 2023 SCImago Journal Rankings: 2.606 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, SH | en_HK |
dc.contributor.author | Cheung, RTF | en_HK |
dc.date.accessioned | 2010-09-06T07:43:23Z | - |
dc.date.available | 2010-09-06T07:43:23Z | - |
dc.date.issued | 2004 | en_HK |
dc.identifier.citation | Journal Of Biomedical Science, 2004, v. 11 n. 6, p. 781-788 | en_HK |
dc.identifier.issn | 1021-7770 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/78483 | - |
dc.description.abstract | In this in vitro study, we investigated the influence of neuropeptide Y (NPY) Y1 receptor activation or inhibition on the viability of cultured neuronal or glial cells following oxygen glucose deprivation (OGD). Viability of cultured cells was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide. When compared to the vehicle-treated control group, treatment with NPY or [Leu31,Pro34]-NPY (Y1 agonist) reduced viability of cultured SK-N-MC (Y1-expressing) human neuronal cells at 24 h after 1 h of OGD, while BIBP3226 (Y1 antagonist) improved viability. Except at the highest concentration of NPY used in the study, treatment with NPY or NPY3-36 (Y2 agonist) did not influence viability of cultured SH-SY5Y (Y2-expressing) human neuronal cells at 24 h after 1 h of OGD. In addition, treatment with NPY, [Leu31,Pro34]-NPY, NPY3-36, or BIBP3226 did not affect viability of cultured primary astrocytes at 24 h after 4 h of OGD. The present results agree with those of a recent in vivo study. Activation of NPY-Y1 receptors may mediate ischemic pathophysiological processes, and inhibiting the Y1 receptors may be protective. The combination of OGD and cultured neuronal cells may be useful in future studies on the neuroprotective and harmful mechanisms of NPY-Y1 receptor inhibition and activation during ischemia, respectively. Copyright © 2004 National Science Council, ROC and S. Karger AG, Basel. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Springer Verlag Dordrecht. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1021-7770 | en_HK |
dc.relation.ispartof | Journal of Biomedical Science | en_HK |
dc.subject | Astrocytes | - |
dc.subject | Cell culture | - |
dc.subject | Neuronal cells | - |
dc.subject | Neuropeptide Y | - |
dc.subject | Neuropeptide Y receptor | - |
dc.subject | Neuroprotection | - |
dc.subject.mesh | Anti-Anxiety Agents - pharmacology | en_HK |
dc.subject.mesh | Arginine - analogs & derivatives - pharmacology | en_HK |
dc.subject.mesh | Astrocytes - metabolism | en_HK |
dc.subject.mesh | Cell Line | en_HK |
dc.subject.mesh | Cell Survival | en_HK |
dc.subject.mesh | Cells, Cultured | en_HK |
dc.subject.mesh | Coloring Agents - pharmacology | en_HK |
dc.subject.mesh | Glucose - metabolism | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Ischemia | en_HK |
dc.subject.mesh | Neuroglia - metabolism | en_HK |
dc.subject.mesh | Neurons - metabolism | en_HK |
dc.subject.mesh | Neuropeptide Y - biosynthesis | en_HK |
dc.subject.mesh | Neuroprotective Agents - pharmacology | en_HK |
dc.subject.mesh | Oxygen - metabolism | en_HK |
dc.subject.mesh | Receptors, Neuropeptide Y - agonists - antagonists & inhibitors - metabolism | en_HK |
dc.subject.mesh | Reperfusion Injury | en_HK |
dc.subject.mesh | Tetrazolium Salts - pharmacology | en_HK |
dc.subject.mesh | Thiazoles - pharmacology | en_HK |
dc.subject.mesh | Time Factors | en_HK |
dc.title | Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1021-7770&volume=11&spage=781&epage=788&date=2004&atitle=Neuropeptide+Y-Y1+receptor+agonist+worsens+while+antagonist+improves+survival+of+cultured+Y1-expressing+neuronal+cells+following+oxygen+and+glucose+deprivation | en_HK |
dc.identifier.email | Cheung, RTF:rtcheung@hku.hk | en_HK |
dc.identifier.authority | Cheung, RTF=rp00434 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1159/000081825 | en_HK |
dc.identifier.pmid | 15591775 | - |
dc.identifier.scopus | eid_2-s2.0-10844274568 | en_HK |
dc.identifier.hkuros | 99209 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-10844274568&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 11 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 781 | en_HK |
dc.identifier.epage | 788 | en_HK |
dc.identifier.isi | WOS:000225547000010 | - |
dc.publisher.place | Netherlands | en_HK |
dc.identifier.scopusauthorid | Chen, SH=12806098400 | en_HK |
dc.identifier.scopusauthorid | Cheung, RTF=7202397498 | en_HK |
dc.identifier.issnl | 1021-7770 | - |